Alta Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Alta Advisers’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492K	Hold	991	–	–	0.11%	93
2026 Q1	$443K	Hold	991	–	–	0.16%	93
2025 Q4	$449K	Sell	991 -280	-22%	-$121K	0.16%	98
2025 Q3	$498K	Hold	1,271	–	–	0.15%	108
2025 Q2	$566K	Hold	1,271	–	–	0.2%	94
2025 Q1	$616K	Buy	1,271 +400	+46%	+$186K	0.26%	81
2024 Q4	$351K	Buy	871 +171	+24%	+$79.3K	0.22%	89
2024 Q3	$326K	Hold	700	–	–	0.15%	79
2024 Q2	$328K	Hold	700	–	–	0.16%	76
2024 Q1	$293K	Hold	700	–	–	0.15%	84
2023 Q4	$285K	Hold	700	–	–	0.15%	80
2023 Q3	$243K	Hold	700	–	–	0.14%	88
2023 Q2	$246K	Hold	700	–	–	0.14%	85
2023 Q1	$221K	Hold	700	–	–	0.13%	93
2022 Q4	$202K	Hold	700	–	–	0.12%	101
2022 Q3	$203K	Buy	+700	New	+$201K	0.13%	87

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Alta Advisers's VRTX Position: Q2 2026 in Review

Alta Advisers held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 991 shares worth $492K. The position accounts for 0.11% of the portfolio, ranked #93.

Alta Advisers first reported a position in VRTX in Q3 2022 and has held it in 16 quarters since. The position peaked at $616K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Alta Advisers held 991 shares of Vertex Pharmaceuticals worth $492K as of Q2 2026.
Alta Advisers left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.11% of Alta Advisers's portfolio in Q2 2026, its #93 holding.
Alta Advisers first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
Alta Advisers's Vertex Pharmaceuticals position peaked at $616K in Q1 2025.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.